Cerebral toxoplasmosis in HIV-infected patients: a review.
Dian S, Ganiem AR, Ekawardhani S.
Pathog Glob Health. 2023 Feb;117(1):14-23. doi: 10.1080/20477724.2022.2083977. Epub 2022 Jun 11.
[Toxoplasma encephalitis].
Yamamoto T.
Nihon Naika Gakkai Zasshi. 2006 Jul 10;95(7):1260-2. doi: 10.2169/naika.95.1260.
Central nervous system infection with Toxoplasma gondii.
Marra CM.
Handb Clin Neurol. 2018;152:117-122. doi: 10.1016/B978-0-444-63849-6.00009-8.
Toxoplasma encephalitis in HIV-infected person.
Yunihastuti E, Imran D, Sukmana N.
Acta Med Indones. 2005 Jan-Mar;37(1):49-50.
Toxoplasmic encephalitis.
Mariuz PR, Luft BJ.
AIDS Clin Rev. 1992:105-30.
Image Diagnosis: Eccentric Target Sign of Focal Toxoplasma Encephalitis.
Verma S, Singla V, Singh A, Bose A, Pannu AK.
Perm J. 2020;24:19.181. doi: 10.7812/TPP/19.181. Epub 2020 Apr 22.
A multimodality therapeutic application on Toxoplasma gondii encephalitis utilizing Spiramycin and 'de novo' Ferula asafetida in immunodeficient mice.
Almurshidi BH, Fahmy Z, El-Shennawy A, Selim EAH, Hammam OA, Okasha H, Al-Hajj W, Mahmoud SA, Abuelenain GL.
Parasite Immunol. 2023 Dec;45(12):e13014. doi: 10.1111/pim.13014. Epub 2023 Oct 9.
Nitric oxide production increases during Toxoplasma gondii encephalitis in mice.
Dincel GC, Atmaca HT.
Exp Parasitol. 2015 Sep;156:104-12. doi: 10.1016/j.exppara.2015.06.009. Epub 2015 Jun 24.
Immunopathogenesis of toxoplasmic encephalitis.
Hunter CA, Remington JS.
J Infect Dis. 1994 Nov;170(5):1057-67. doi: 10.1093/infdis/170.5.1057.
Toxoplasmic encephalitis in AIDS.
Luft BJ, Remington JS.
Clin Infect Dis. 1992 Aug;15(2):211-22. doi: 10.1093/clinids/15.2.211.
